Merck shares tumble on Q4 earnings miss, weak 2025 guidance

Investing.comFeb 4, 2025 12:26 PM

View all comments（0）



Investing.com -- Merck &Company Inc (NYSE:MRK) shares tumbled more than 8% on pre-market trading on Tuesday after reporting mixed fourth-quarter results, with earnings falling short of expectations, revenue surpassing estimates and full-year guidance coming in below analyst projections.

Merck (NSE:PROR) posted adjusted earnings per share (EPS) of $1.72 for Q4, missing the analyst consensus of $1.81 by $0.09. However, revenue for the quarter came in at $15.6 billion, beating the expected $15.47 billion. Compared to the same quarter last year, revenue increased 7%, or 9% excluding foreign exchange impacts.

The company forecasts full-year 2025 adjusted EPS of $8.88 to $9.03, below the consensus estimate of $9.21. Revenue is projected to be between $64.1 billion and $65.6 billion, also lower than the $67.36 billion analysts were expecting.

For the full year 2024, Merck reported worldwide sales of $64.2 billion, up 7% YoY or 10% excluding foreign exchange effects. The company's blockbuster cancer drug KEYTRUDA continued to drive growth, with sales rising 18% to $29.5 billion for the year.

"We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including for KEYTRUDA, which continues to benefit more patients with cancer globally, the successful launch of WINREVAIR and strong performance of our Animal Health business," said Robert M. Davis, chairman and CEO of Merck.

Merck also said that it is planning to temporarily pause shipments of GARDASIL/GARDASIL 9 to China beginning February 2025 through at least mid-year, which is reflected in the guidance.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Tesla Stock Forecast: TSLA Triangle Breakout Targets $411.90 as Cybercabs Overtake Model Ys

TradingKey - Tesla stock forecast: TSLA breaks out of a triangle above $388.85 as Cybercabs overtake Model Ys in Texas, with $411.90 the next hurdle on the 4-hour chart.

Micron Rises Over 3% Pre-Market as Musk Predicts Robot Memory Demand Will Surpass Other Sectors

TradingKey - In pre-market trading on October 28 ET, as of press time, Micron Technology (MU) rose 3.8% to $964.02.

SK Hynix Surges Over 4% as Q3 Results Hit Record High, Returning $75 Billion to Shareholders

SK Hynix reported a record-breaking Q3 operating profit while announcing a massive 100 trillion won (approximately $75 billion) shareholder return plan, sending its stock price surging 4%.

KOSPI Tops 5,800, Kioxia Jumps Over 4% as SK Hynix Revenue and Profit Hit Record Highs

The KOSPI surged over 3%, Kioxia jumped 4%, Samsung and SoftBank joined the rally, and SK Hynix unveiled a massive 100 trillion KRW in shareholder returns.

US Stocks Close: Nasdaq Rises Over 1%, Philadelphia Semiconductor Index Gains Over 3%; Chip Stocks Extend Rally, CoreWeave Gains Nearly 8%

On Tuesday, October 27, Eastern Time, U.S. stocks moved higher, with chip stocks extending their rally to drive the Nasdaq to lead the gains. Amid falling oil prices, investors continued to assess a heavy slate of corporate earnings reports while focusing on the Federal Reserve's interest rate meeting. At the close, the Dow Jones Industrial Average rose 0.03% to 52,377.57 points; the Nasdaq Composite Index gained 1.18% to 26,477.81 points; and the S&P 500 Index advanced 0.60% to 7,722.60 points.

Featured Tools